Epidermolysis Bullosa: Clinical Trails

(asked on 4th July 2022) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will commit additional funding for clinical trials on the repurposing of drugs to treat Epidermolysis Bullosa; and if he will make a statement.


Answered by
James Morris Portrait
James Morris
This question was answered on 12th July 2022

The Department funds research through the National Institute for Health and Care Research (NIHR). While the usual practice of the NIHR is not to ring-fence funds for expenditure on particular topics, the NIHR welcomes funding applications for research into any aspect of health or care research, including trials for the repurposing of drugs for conditions such as Epidermolysis Bullosa. These applications are subject to peer review and judged in open competition, with awards made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.

Reticulating Splines